journal article Apr 01, 2017

Guidelines on the management of drug‐induced immune and secondary autoimmune, haemolytic anaemia

British Journal of Haematology Vol. 177 No. 2 pp. 208-220 · Wiley
View at Publisher Save 10.1111/bjh.14654
Topics

No keywords indexed for this article. Browse by subject →

References
121
[15]
Comerci J.T. "Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature" Obstetrics and Gynecology (1994)
[19]
Dacie J.V. (1962)
[20]
Dacie J.V. "Auto‐immune hemolytic anemias" Progress in Hematology (1969)
[24]
Drobyski W.R. "Autoimmune hemolytic anemia following T cell‐depleted allogeneic bone marrow transplantation" Bone Marrow Transplantation (1996)
[28]
Evans R.S. "Acquired hemolytic anemia; the relation of erythrocyte antibody production to activity of the disease; the significance of thrombocytopenia and leukopenia" Blood (1949)

Showing 50 of 121 references

Cited By
123
Clinical Infection in Practice
Anemia in the pediatric patient

Patrick G. Gallagher · 2022

Blood
Autoimmune Hemolytic Anemias

Sigbjørn Berentsen, Wilma Barcellini · 2021

New England Journal of Medicine
Transfusion Clinique et Biologique
Metrics
123
Citations
121
References
Details
Published
Apr 01, 2017
Vol/Issue
177(2)
Pages
208-220
License
View
Cite This Article
Quentin A. Hill, Robert Stamps, Edwin Massey, et al. (2017). Guidelines on the management of drug‐induced immune and secondary autoimmune, haemolytic anaemia. British Journal of Haematology, 177(2), 208-220. https://doi.org/10.1111/bjh.14654